Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine
Lindsay Zilliox1, James W Russell1,21Department of Neurology, Neuromuscular Division, The University of Maryland School of Medicine, 2VA Maryland Health Care System, Baltimore, MD, USAIntroduction: Neuropathy is one of the most frequent complications of diabetes. Of all the symptoms ass...
Guardado en:
Autores principales: | Lindsay Zilliox, James W Russell |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/94c2030669a24a1399b0e655308a7905 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine
por: Russell J, et al.
Publicado: (2010) -
Role and development of GLP-1 receptor agonists in the management of diabetes
por: Chee W Chia, et al.
Publicado: (2009) -
Association of patient-rated severity with other outcomes in patients with painful diabetic peripheral neuropathy
por: Taylor-Stokes G, et al.
Publicado: (2011) -
Peroxisome proliferator-activated receptors as stimulants of angiogenesis in cardiovascular disease and diabetes
por: Cyrus V Desouza, et al.
Publicado: (2009) -
Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey
por: Sadosky A, et al.
Publicado: (2013)